Viemed Healthcare, Inc. (NASDAQ:VMD)
Insiders here have filed 7 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Profitable, but on a thin margin.
- Revenue
- $301.6M
- Net income
- $14.5M
- Net margin
- 4.8%
Little or no net debt.
- Total debt
- $11.6M
- Cash
- $10.7M
- Net debt / EBITDA
- 0.02x
Covers near-term obligations, without much room.
- Current assets
- $54.0M
- Current liabilities
- $47.9M
- Current ratio
- 1.13
The business funds itself from operations.
- Operating cash flow
- $60.8M
- Free cash flow
- $29.2M
- FCF margin
- 9.7%
Not funding itself by issuing shares.
- Shares outstanding
- 38.2M
- Share growth (1y)
- -3.2%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 78.10 M | 75.41 M | 76.18 M | 71.91 M | 63.06 M | 59.13 M |
| Revenue Growth (YoY) | 23.85 % | 27.54 % | 25.51 % | 23.98 % | 14.72 % | 16.87 % |
| Cost of Revenue | 33.44 M | 32.98 M | 32.08 M | 30.57 M | 26.68 M | 25.85 M |
| Gross Profit | 44.66 M | 42.44 M | 44.10 M | 41.34 M | 36.38 M | 33.28 M |
| SG&A Expense | 39.16 M | 34.79 M | 34.52 M | 34.10 M | 31.09 M | 30.74 M |
| R&D Expense | 504.00 K | 579.00 K | 598.00 K | 775.00 K | 847.00 K | 797.00 K |
| Operating Expenses | 39.60 M | 37.71 M | 35.44 M | 35.23 M | 31.87 M | 29.44 M |
| Operating Income | 5.06 M | 4.73 M | 8.66 M | 6.12 M | 4.51 M | 3.84 M |
| Pretax Income | 4.05 M | 3.99 M | 8.01 M | 5.13 M | 4.96 M | 3.66 M |
| Tax Provision | 1.15 M | 1.28 M | 2.19 M | 1.53 M | 1.71 M | 952.00 K |
| Net Income | 2.76 M | 2.58 M | 5.64 M | 3.51 M | 3.16 M | 2.63 M |
| EPS (Basic) | 0.07 | 0.07 | 0.15 | 0.09 | 0.08 | 0.07 |
| EPS (Diluted) | 0.07 | 0.06 | 0.14 | 0.09 | 0.08 | 0.06 |
| Shares Outstanding | 38.25 M | 38.43 M | 38.02 M | 38.64 M | 39.52 M | 39.43 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.